BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25650546)

  • 1. The NK1 receptor antagonist aprepitant attenuates NK1 agonist-induced scratching behaviour in the gerbil after intra-dermal, topical or oral administration.
    Costantini VJ; Corsi M; Dünstl G; Bettelini L; Zonzini L; Gerrard P
    Exp Dermatol; 2015 Apr; 24(4):312-4. PubMed ID: 25650546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour.
    Trower MK; Fisher A; Upton N; Ratti E
    Exp Dermatol; 2014 Nov; 23(11):858-60. PubMed ID: 25078633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis.
    Lönndahl L; Holst M; Bradley M; Killasli H; Heilborn J; Hall MA; Theodorsson E; Holmberg J; Nordlind K
    Acta Derm Venereol; 2018 Mar; 98(3):324-328. PubMed ID: 29182791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
    Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J
    Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists.
    Duffy RA; Varty GB; Morgan CA; Lachowicz JE
    J Pharmacol Exp Ther; 2002 May; 301(2):536-42. PubMed ID: 11961054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice.
    Andoh T; Nagasawa T; Satoh M; Kuraishi Y
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1140-5. PubMed ID: 9732370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom.
    Costa SK; Starr A; Hyslop S; Gilmore D; Brain SD
    Vascul Pharmacol; 2006 Oct; 45(4):209-14. PubMed ID: 16914387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
    Watanabe Y; Asai H; Ishii T; Kiuchi S; Okamoto M; Taniguchi H; Nagasaki M; Saito A
    J Pharmacol Sci; 2008 Jan; 106(1):121-7. PubMed ID: 18187929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist.
    Ballard TM; Sänger S; Higgins GA
    Eur J Pharmacol; 2001 Feb; 412(3):255-64. PubMed ID: 11166289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.
    Griffante C; Carletti R; Andreetta F; Corsi M
    Br J Pharmacol; 2006 May; 148(1):39-45. PubMed ID: 16501582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal actions of GR73632, a novel tachykinin NK1 receptor agonist.
    Sakurada C; Watanabe C; Inoue M; Tan-No K; Ando R; Kisara K; Sakurada T
    Peptides; 1999; 20(2):301-4. PubMed ID: 10422886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP.
    Andoh T; Kuraishi Y
    J Dermatol Sci; 2014 Dec; 76(3):206-13. PubMed ID: 25458869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the chloroquine-induced mouse model of pruritus using an automated behavioural system.
    Tarrasón G; Carcasona C; Eichhorn P; Pérez B; Gavaldà A; Godessart N
    Exp Dermatol; 2017 Nov; 26(11):1105-1111. PubMed ID: 28605064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state.
    te Beek ET; Tatosian D; Majumdar A; Selverian D; Klaassen ES; Petty KJ; Gargano C; van Dyck K; McCrea J; Murphy G; van Gerven JM
    J Clin Pharmacol; 2013 Aug; 53(8):846-56. PubMed ID: 23775877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test.
    Varty GB; Cohen-Williams ME; Hunter JC
    Behav Pharmacol; 2003 Feb; 14(1):87-95. PubMed ID: 12576885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
    Di Fabio R; Alvaro G; Braggio S; Carletti R; Gerrard PA; Griffante C; Marchioro C; Pozzan A; Melotto S; Poffe A; Piccoli L; Ratti E; Tranquillini E; Trower M; Spada S; Corsi M
    Bioorg Med Chem; 2013 Nov; 21(21):6264-73. PubMed ID: 24075145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.
    Duffy RA; Hedrick JA; Randolph G; Morgan CA; Cohen-Williams ME; Vassileva G; Lachowicz JE; Laverty M; Maguire M; Shan LS; Gustafson E; Varty GB
    Neuropharmacology; 2003 Aug; 45(2):242-50. PubMed ID: 12842130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.